about
Iranian consensus on use of vitamin D in patients with multiple sclerosisUses of complementary and alternative medicine in multiple sclerosisThe effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.A study on the direct and indirect costs of multiple sclerosis based on expanded disability status scale score in khuzestan, iran.Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan.Several food items and multiple sclerosis: A case-control study in Ahvaz (Iran).A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.Riboflavin supplementation to patients with multiple sclerosis does not improve disability status nor is riboflavin supplementation correlated to homocysteine.Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life.Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations.Predicting falls among patients with multiple sclerosis: Comparison of patient-reported outcomes and performance-based measures of lower extremity functions.Critical role of SDF-1/CXCR4 signaling pathway in stem cell homing in the deafened rat cochlea after acoustic trauma.Diagnostic evaluation of dysphagia in multiple sclerosis patients using a Persian version of DYMUS questionnaire.The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trial.Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: a double-blind, randomized controlled pilot trial.The effects of cognitive loading on balance control in patients with multiple sclerosis.Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trialAcute responses of cytokines and adipokines to aerobic exercise in relapsing vs. remitting women with multiple sclerosisExercise-induced changes in neurotrophic factors and markers of blood-brain barrier permeability are moderated by weight status in multiple sclerosisThe Effect of Mindfulness-Based Stress Reduction (MBSR) Therapy on Quality of Life in Women with Multiple Sclerosis, Ahvaz, Iran
P50
Q28067025-97CCF4D0-D885-47EB-B01B-D798786B2B04Q34080792-1A867625-F26E-4E27-91A2-07D9BDF8A050Q34119868-608787B8-099A-4572-8134-A8750C7763FCQ34318626-47FC1539-8970-4FCE-9259-10F89A7AE6ADQ34558990-628F5601-B329-4670-9070-954C3A2733D8Q34794204-3854D1CD-7708-4113-A436-ADB88963BDBEQ36582951-102CF4B0-D18E-42EC-8464-E184F6D77CC3Q38850911-6C46CC52-CAEF-46E6-BE3F-01C2A39A5136Q43806164-F0293100-003E-410E-9AE9-497F8E5951E1Q45399787-9AE5D1FA-E7A2-47F4-A409-B0B2CB8C1817Q47558335-31577067-9703-4A55-B0B5-398E01F9817FQ47590986-0D4A421E-81DA-41BA-89C9-CE60F61E6115Q47884926-B76321D8-0C8E-4A14-845E-694881293844Q49939569-10C239DF-3F70-4208-B373-36CA184FC77BQ50063655-D4085891-1B25-4E74-8085-490CA5398B71Q50686558-327B2CC2-7A2F-4914-ADB5-60839390D494Q53811988-7D67F0F4-FF25-43FB-8D2B-44E9597B4A0EQ64894518-49641549-EEC1-40AA-BAC1-408B75546751Q84520360-F4C062C5-6212-4438-9DAE-2A8638FC0EF4Q88503656-84B15CC1-68D8-4179-AFC9-12A3B54EFD08Q89029656-68B9D7AD-CD44-46E7-9578-583839DB5EF1Q92505090-8782D3C4-75E4-4C9E-A885-DE9A0C1C94C4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nastaran Majdinasab
@ast
Nastaran Majdinasab
@en
Nastaran Majdinasab
@es
Nastaran Majdinasab
@nl
Nastaran Majdinasab
@sl
type
label
Nastaran Majdinasab
@ast
Nastaran Majdinasab
@en
Nastaran Majdinasab
@es
Nastaran Majdinasab
@nl
Nastaran Majdinasab
@sl
prefLabel
Nastaran Majdinasab
@ast
Nastaran Majdinasab
@en
Nastaran Majdinasab
@es
Nastaran Majdinasab
@nl
Nastaran Majdinasab
@sl
P106
P1153
36195868400
P31
P496
0000-0001-5163-7210